Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA7 | P43166 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 4/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.56 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3510775 | 0.92 | CA12 (0.64) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL16850624 | 0.92 | KDM4E (0.68) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL2759061 | 0.92 | CA12 (0.64) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL16175866 | 0.92 | KDM4E (0.68) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL13307515 | 0.87 | CA12 (0.58) | KDM4ECA12CA1CA2CA7 | |
| SCHEMBL4731536 | 0.86 | CA1 (0.60) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL2759065 | 0.85 | CYP2C19 (0.62) | KDM4ECA12CA1CA2CA7 | |
| SCHEMBL30195103 | 0.85 | CYP2C9 (0.62) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL1664013 | 0.84 | CA12 (0.75) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL20991487 | 0.84 | CA12 (0.59) | KDM4EALDH1A1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629266-B2 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-14 | — | — | US | disclosed |
| US-20130116422-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-8382889-B1 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116422-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | CD14, STT3B, STT3A | KDM4E 3035/4885ALDH1A1 2310/4885CA12 3790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.